AAAAAA
Results:
1-15
|
Results: 15
Authors:
SEGELOV E
MANN G
DEFAZIO A
HARNETT PR
Citation: E. Segelov et al., MECHANISMS DETERMINING SENSITIVITY TO CISPLATIN IN 3 MUTANT CHINESE-HAMSTER OVARY CELL-LINES, Mutation research. DNA repair, 407(3), 1998, pp. 243-252
Authors:
HAHLIN M
JAWORSKI RC
WAIN GV
HARNETT PR
NEESHAM D
BULL C
Citation: M. Hahlin et al., INTEGRATED MULTIMODALITY THERAPY FOR EMBRYONAL RHABDOMYOSARCOMA OF THE LOWER GENITAL-TRACT IN POSTPUBERTAL FEMALES, Gynecologic oncology (Print), 70(1), 1998, pp. 141-146
Authors:
CURROW DC
FINDLAY M
COX K
HARNETT PR
Citation: Dc. Currow et al., ELEVATED GERM-CELL MARKERS IN CARCINOMA OF UNCERTAIN PRIMARY SITE DO NOT PREDICT RESPONSE TO PLATINUM-BASED CHEMOTHERAPY, European journal of cancer, 32A(13), 1996, pp. 2357-2359
Authors:
KING MT
DOBSON AJ
HARNETT PR
Citation: Mt. King et al., A COMPARISON OF 2 QUALITY-OF-LIFE QUESTIONNAIRES FOR CANCER CLINICAL-TRIALS - THE FUNCTIONAL LIVING INDEX-CANCER (FLIC) AND THE QUALITY-OF-LIFE QUESTIONNAIRE CORE MODULE (QLQ-C30), Journal of clinical epidemiology, 49(1), 1996, pp. 21-29
Authors:
WITHAM M
HARNETT PR
Citation: M. Witham et Pr. Harnett, ADENOCARCINOMA OF THE DUODENUM WITH LIVER METASTASES - COMPLETE REMISSION AND LONG-TERM SURVIVAL WITH 5-FLUOROURACIL CHEMOTHERAPY - A CASE-REPORT, American journal of clinical oncology, 19(3), 1996, pp. 305-306
PRIMARY PERITONEAL CARCINOMA - A TREATABLE SUBSET OF PATIENTS WITH ADENOCARCINOMA OF UNKNOWN PRIMARY
Authors:
DELLAFIORENTINA SA
JAWORSKI RC
CRANDON AJ
HARNETT PR
Citation: Sa. Dellafiorentina et al., PRIMARY PERITONEAL CARCINOMA - A TREATABLE SUBSET OF PATIENTS WITH ADENOCARCINOMA OF UNKNOWN PRIMARY, Australian and New Zealand journal of surgery, 66(2), 1996, pp. 124-125
Authors:
SHANNON JA
DONNELLAN MJ
FRIEDLANDER ML
HARNETT PR
Citation: Ja. Shannon et al., PERSISTING ELEVATION OF ALPHA-FETOPROTEIN AFTER CHEMOTHERAPY FOR GERM-CELL TUMOR - NOT ALWAYS DUE TO VIABLE MALIGNANCY, European journal of cancer, 31A(10), 1995, pp. 1722-1722
Authors:
SEGELOV E
MANN GJ
HARNETT PR
Citation: E. Segelov et al., CHARACTERIZATION OF A NOVEL CISPLATIN-SENSITIVE MAMMALIAN MUTANT-CELLLINE, Journal of cellular biochemistry, 1995, pp. 286-286
Authors:
IRELAND CM
PITMAN SM
JONES SL
HARNETT PR
Citation: Cm. Ireland et al., ESTABLISHMENT OF AN IN-VITRO MODEL FOR CISPLATIN RESISTANCE IN HUMAN NEUROBLASTOMA CELL-LINES, Anticancer research, 14(6B), 1994, pp. 2397-2403
Authors:
HARNETT PR
Citation: Pr. Harnett, UNTITLED, Medical journal of Australia, 161(9), 1994, pp. 572-572
Authors:
JONES SL
HICKSON ID
HARRIS AL
HARNETT PR
Citation: Sl. Jones et al., REPAIR OF CISPLATIN-DNA ADDUCTS BY PROTEIN EXTRACTS FROM HUMAN OVARIAN-CARCINOMA, International journal of cancer, 59(3), 1994, pp. 388-393
Authors:
JONES SL
HARNETT PR
Citation: Sl. Jones et Pr. Harnett, HETEROGENEOUS REPAIR OF PLATINUM-DNA ADDUCTS BY PROTEIN EXTRACTS FROMMAMMALIAN-TISSUES, Biochemical pharmacology, 48(8), 1994, pp. 1662-1665
Authors:
JONES SL
HARNETT PR
Citation: Sl. Jones et Pr. Harnett, HETEROGENEOUS REPAIR OF PLATINUM-DNA ADDUCTS BY PROTEIN EXTRACTS FROMMAMMALIAN-TISSUES, Biochemical pharmacology, 48(8), 1994, pp. 1662-1665
Authors:
SMITH RD
HALL J
GURNEY H
HARNETT PR
Citation: Rd. Smith et al., A COST-UTILITY APPROACH TO THE USE OF 5-FLUOROURACIL AND LEVAMISOLE AS ADJUVANT CHEMOTHERAPY FOR DUKES C-COLONIC CARCINOMA - REPLY, Medical journal of Australia, 158(12), 1993, pp. 866-866
Authors:
GOLDRICK A
HARNETT PR
Citation: A. Goldrick et Pr. Harnett, VERTEBRAL OSTEOMYELITIS IN ADVANCED BREAST-CANCER, Australian and New Zealand Journal of Medicine, 23(4), 1993, pp. 406-406
Risultati:
1-15
|